S
Staidson Hongkong Investment Company
Investments
1
Lead Investments
0
Staidson Hongkong Investment Co. Ltd. (STS) is an innovative biopharmaceutical company dedicated to research and development, production, and investment in the healthcare and pharmaceuticals sector. It is a wholly owned unit of Staidson (Beijing) Biopharmaceuticals Co., Ltd., and is involved in significant investments such as the $20 million investment in the New China Innovation Fund.
Highlights
Focus Areas
Health Care
Medical
Pharmaceutical
Therapeutics
Notable Investments
